How much does CJC-1295 ipamorelin cost per month?

There is no single figure, because no manufacturer markets an approved version of this blend and so no list price exists. What you are quoted is a service price: a prescription route bundles the medical evaluation, the medication, shipping and follow-up into one monthly number, while a vial sold on its own prices only the vial. Promise's current monthly price is shown on the CJC-1295 / Ipamorelin product page.

Why does the blend cost more than sermorelin?

Two active ingredients instead of one. Each peptide is sourced separately, arrives with its own certificate of analysis, and has to be identified and assayed on its own before anything is combined. The sterile work on the finished vial costs roughly the same either way; it is the ingredient and quality-control side that doubles. A sermorelin vial also covers 30 days against the blend's 28.

Does insurance cover CJC-1295 and ipamorelin?

Generally not. Insurers pay against approved products that carry billing codes, and a compounded preparation of a molecule with no approved version usually has neither. That is why almost everyone pays cash for this category. Whether an HSA or FSA card will process the charge depends on your plan administrator, so ask them rather than assuming either way.

Is CJC-1295 / Ipamorelin FDA-approved?

No. There is no FDA-approved CJC-1295 or ipamorelin product marketed in the United States, and the compounded blend prescribed here is not FDA-approved. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. A licensed provider may still prescribe a compounded formulation when they judge it appropriate, and that decision is between you and your doctor.

Why are peptide vials sold online so much cheaper?

Because the price covers a vial and nothing else. No clinician reads your history, no pharmacy is accountable for what is inside, and there is no one to call if something goes wrong. A 2026 review in Cureus described the core problem as products of uncertain identity, purity, potency, sterility and safety. The saving is real, and so is what it leaves out.

CJC-1295 Ipamorelin Cost: What the Price Covers

CJC-1295 ipamorelin cost depends almost entirely on which route you take, because there is no brand-name version of this blend and so no list price to argue with. Every figure you find online is somebody's cash price — either for a compounded prescription filled by a licensed pharmacy, or for a vial sold as laboratory material with no clinician anywhere in the transaction.

Those two numbers are not measuring the same thing. One of them includes a doctor.

Why CJC-1295 ipamorelin cost has no list price

A list price exists when a manufacturer has an approved product to put a number on. Neither peptide in this blend has one in the United States, and the compounded blend prescribed here is not FDA-approved. There is no reference figure and no insurance code, so nothing anchors the market.

What exists instead is compounding — a licensed pharmacy preparing a medication for one named patient, on a prescription. How compounded medications are made covers what that work involves. The number you are quoted is a service price, and services differ.

Where these two peptides sit with regulators shapes who is willing to make the blend at all, which in turn shapes what it costs. FDA keeps a running list of ingredients nominated for use in compounding that the agency has open safety questions about. Ipamorelin acetate has sat in category 2 of that list since September 29, 2023, on the outsourcing-facility side of the rules, and the nomination covering CJC-1295 was withdrawn by the people who filed it. Both entries are on FDA's page of bulk substances that may present significant safety risks, current as of April 22, 2026.

That is a fact about paperwork, not a verdict on you. A licensed provider may still prescribe a compounded formulation, and that decision is between you and your doctor. What it means in practice is that a preparation like this comes from a pharmacy filling one prescription at a time rather than from a plant making batches for stock — and that route has its own cost structure.

What a prescription price covers

A quoted price only means something once you know what sits behind it. At Promise the monthly figure covers the online medical evaluation by a licensed provider, the prescription itself if that provider decides the blend is appropriate for you, compounding and dispensing by a licensed U.S. pharmacy, temperature-safe shipping, and follow-up check-ins. The vial that arrives is a 28-day supply.

Hold that list up against anything you compare it to. A vial price with a separate consultation fee, a shipping charge and a refill fee bolted on is not the number it looked like on the first screen.

Insurance is usually not part of this picture. Plans pay against approved products with billing codes attached, and a compounded preparation of an unapproved molecule generally has neither. Whether an HSA or FSA card will go through is a question for your plan administrator — not something a clinic can settle for you in advance.

What a cheap vial actually costs

The gap between a prescription price and a bargain vial is real, and so is what the bargain leaves out.

A review published in June 2026 in Cureus looked at how these products reach people through online wellness and biohacking channels. Its authors were careful to say the concern is not peptide medicine itself but "consumer experimentation with products of uncertain identity, purity, potency, sterility, and safety" (Hailu et al., Cureus 2026). Uncertain identity is the part people underestimate. You are not weighing two prices for the same thing — you are weighing a documented preparation against an unknown one.

Whether peptides can be bought over the counter covers that route in more detail, including what the labels on those vials are telling you and where the legal lines fall.

What the evidence says you are paying for

Price is only half of value, so it is worth being straight about the other half.

As of September 6, 2026, the day this article was written, the newest published look at these compounds is a scoping review from a UCLA orthopaedic group, posted online on August 11, 2026 in the American Journal of Sports Medicine. It went through the literature on six peptides marketed for recovery and performance — CJC-1295 and ipamorelin among them — and found that about two thirds of the published work was done in animals, mostly rats, with only a handful of human studies, most of those lacking solid controls. For musculoskeletal recovery and performance specifically, the authors concluded the claimed benefits "remain unsubstantiated by current human trials" (Tewari et al., Am J Sports Med 2026). A narrative review published in Sports Medicine earlier the same year landed in a similar place, describing rigorous human safety data for the unapproved peptides in this group as scarce (Mendias and Awan, Sports Med 2026).

None of that makes the category worthless, and none of it makes a price good value on its own. It is the honest state of the evidence, and it belongs in a spending decision. A licensed provider may still decide a compounded formulation fits your history — that call is between the two of you.

One more thing worth separating out: familiarity is not evidence. Ipamorelin has been in the literature since 1998, when a Danish group described it as the first selective growth hormone secretagogue — a molecule that prompts the pituitary gland to release growth hormone without dragging cortisol and prolactin up alongside it (Raun et al., Eur J Endocrinol 1998). Twenty-eight years of a name in journals is not the same as twenty-eight years of outcome trials, and the two get confused constantly.

Why the blend costs more than a single peptide

Two peptides in one vial means two of nearly everything upstream. Each active ingredient is sourced on its own, arrives with its own certificate of analysis, and has to be identified and assayed separately before anything is combined.

Peptides are also harder to characterise than ordinary small-molecule drugs, and FDA says so plainly on the page linked above: ipamorelin contains unnatural amino acids that "add to the complexity of peptide characterization", and both peptides carry open questions about impurities left behind by synthesis. Difficult testing is expensive testing.

The sterile side of the work — the clean room, the filtration, the sterility and endotoxin checks on the finished vial — happens either way. It is the ingredient and quality-control side that doubles.

That is why the blend sits above a single-peptide option like sermorelin, even though a sermorelin vial covers 30 days against the blend's 28. Sermorelin versus CJC-1295 sets out what the extra actually buys, and why CJC-1295 and ipamorelin are prescribed together explains what the second peptide is there to do. If the pairing is not doing something you need, the simpler option is not a downgrade.

Three questions worth asking before you pay

What is included, item by item? Evaluation, prescription, medication, shipping, refills, follow-up. Anything missing from that list is a separate bill waiting to happen.

How long does one vial last? A monthly figure means nothing until you know whether it covers 28 days or 30, and whether a change in protocol changes the supply.

Who is accountable if something is wrong? A prescription gives you a named provider and a licensed pharmacy on the other end of the phone. A vial ordered from a website gives you a shipping confirmation.

A licensed provider reviews every request here, and not everyone qualifies. Nobody is charged for a prescription that is not written, which is worth knowing before you set any two numbers side by side.